| Identification | Back Directory | [Name]
TOFISOPAM | [CAS]
22345-47-7 | [Synonyms]
SERIEL
Tosopam
EGYT 341
grandaxin
TOFISOPAM
tofizopam
Tofisopam, >=99%
TOFISOPAM 22345-47-7
7-CHLORO-1-METHYL-5-PHENYL-1,5-BENZODIAZEPINE-2,4-DIONE
-5-ethyl-7,8-dimethoxy-4-methyl-5H-benzo[d][1,2]diazepine
1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-3-benzodiazepine
1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine
7,8-DIMETHOXY-1-(3,4-DIMETHOXYPHENYL)-5-ETHYL-4-METHYL-5H-2,3-BENZODIAZEPINE
1-(3,4-Dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepine
5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-
1-(3,4-Dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-benzo[d][1,2]diazepine
1-[3,4-Bis(methyloxy)phenyl]-5-ethyl-4-methyl-7,8-bis(methyloxy)-5H-2,3-benzodiazepine
1-(3,4-DiMethoxyphenyl)-5-ethyl-7,8-diMethoxy-4-Methyl-5H-2,3-benzodiazepine (TofisopaM)
5H-2,3-Benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl- (8CI, 9CI)
EGYT 341, Seriel, 7,8-Dimethoxy-1-(3,4-dimethoxyphenyl)-5-ethyl-4-methyl-5H-2,3-benzodiazepine
TofisopamQ: What is
Tofisopam Q: What is the CAS Number of
Tofisopam Q: What is the storage condition of
Tofisopam Q: What are the applications of
Tofisopam | [EINECS(EC#)]
244-922-3 | [Molecular Formula]
C22H26N2O4 | [MDL Number]
MFCD00823171 | [MOL File]
22345-47-7.mol | [Molecular Weight]
382.45 |
| Chemical Properties | Back Directory | [Melting point ]
155-159°C | [Boiling point ]
509.61°C (rough estimate) | [density ]
1.2098 (rough estimate) | [refractive index ]
1.6500 (estimate) | [solubility ]
DMSO: ~14 mg/mL
| [form ]
solid
| [pka]
7.29±0.40(Predicted) | [color ]
white
| [λmax]
310nm(MeOH)(lit.) | [Merck ]
14,9503 | [Stability:]
Hygroscopic | [InChI]
1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3 | [InChIKey]
RUJBDQSFYCKFAA-UHFFFAOYSA-N | [SMILES]
CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c3cc(OC)c(OC)cc13 |
| Safety Data | Back Directory | [Symbol(GHS) ]
 
GHS07,GHS09 | [Signal word ]
Warning | [Hazard statements ]
H302-H400 | [Precautionary statements ]
P273-P301+P312+P330 | [Hazard Codes ]
Xn,N | [Risk Statements ]
22-50 | [Safety Statements ]
60-61 | [RIDADR ]
UN 3077 9/PG 3
| [WGK Germany ]
2
| [RTECS ]
DE9540000
| [HS Code ]
2933.99.8290 | [HazardClass ]
6.1(b) | [PackingGroup ]
III | [Storage Class]
11 - Combustible Solids | [Hazard Classifications]
Acute Tox. 4 Oral
Aquatic Acute 1 |
| Hazard Information | Back Directory | [Originator]
Grandaxine,Ozothine,France,1975 | [Uses]
Tofisopam is a reagent used in preparation of allosteric ligands for pharmacological dark receptors GPR68 and GPR65. An anticonvulsant. | [Definition]
ChEBI: Tofisopam is an organic molecular entity. | [Manufacturing Process]
A mixture of 38.6 g (0.1 mol) of 3,4,3',4'-tetramethoxy-6-(α-acetopropyl)-
benzophenone, 5.5 g (0.11 mol) of 100% hydrazine hydrate or 3.52 g (0.11
mol) of hydrazine, and 500 ml of absolute ethanol is boiled for 5 hours. After adding 100 ml of benzene, 400 ml of solvent mixture is distilled off from the
reaction mixture by slow boiling for 3 hours. After cooling for 8 hours, 19 g of
5H-2,3-benzodiazepine derivative are separated from the residue as small,
white crystals. The melting point is 133°C to 136°C (after recrystallizing from
absolute ethanol, 136°C) | [Therapeutic Function]
Tranquilizer | [Biological Activity]
Studies have reported th at tofisopam functions by blocking PDE4 (phosphodiesterase 4). Furthermorethe S-enantiomer of tofisopam is considered ten times more active than R-enantiomer.''Ligand for the GABAA receptor benzodiazepine modulatory site. |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Telephone: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm |
| Company Name: |
LETOPHARM LIMITED
|
| Telephone: |
+86-21-5821 5861 |
| Website: |
www.letopharm.com |
| Company Name: |
Struchem Co., Ltd.
|
| Telephone: |
0512-63009836 18994340901 |
| Website: |
http://www.beidapharma.com |
|